Venomous Snakebite Treatments in South India: A Cost-Effectiveness Analysis
Snake envenomation is a severely neglected global health issue, with greatest impact in the rural tropics of India and Sub-Saharan Africa. Antivenom (AV) is the standard treatment for snake envenomation, but the high cost and limited efficacy of AV indicate the need for improved snake venom antidotes. This study seeks to analyze the costeffectiveness of treating snake envenomation with an inhibitor-based approach, used in conjunction with traditional AV.
Mentors: Matt Lewin, MD, PhD and Jim Kahn, MD, MPH